Patent intelligence · US
US 6806363
Cobalamin conjugates useful as antitumor agents
Cobalamin conjugates useful as antitumor agents
Patent details — US 6806363
- Jurisdiction
- US
- Status
- expired
- Grant date
- Oct 19, 2004
- Expiration
- Oct 14, 2024
- Applicant
- Minnesota, Regents of the University
- Claims
- 57
- CPC classes
- A61K, A61K41/0095
Quick answer
US 6806363 (Cobalamin conjugates useful as antitumor agents) is held by Minnesota, Regents of the University. Status: expired. Granted Oct 19, 2004. Expires Oct 14, 2024 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Minnesota, Regents of the University
- Grant date
- Expiration
- Claims
- 57
- CPC classes
- A61K, A61K41/0095
More from Minnesota, Regents of the University
Related pharmaceutical patents in our USPTO index.
-
US 12428463
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted
Frequently asked questions
What is US patent 6806363?
US 6806363 (Cobalamin conjugates useful as antitumor agents) is held by Minnesota, Regents of the University. Status: expired. Granted Oct 19, 2004. Expires Oct 14, 2024 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6806363?
Minnesota, Regents of the University is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.
When does US 6806363 expire?
Our index shows an expiration date of Oct 14, 2024 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.